Home
/ Novavax
/ Competitors

Novavax Competitors and Similar CompaniesClear all

Novavax's competitors and similar companies include Metabolon and Adaptimmune.

	Novavax Novavax is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases.	Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.	Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Founding Date	Founding Date 1987	Founding Date 2000	Founding Date 2008
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare Manufacturing & Industrial Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech pharma
Locations	Locations Gaithersburg, US HQ Jevany, CZ Uppsala, SE Rockville, US	Locations Morrisville, US HQ Hallbergmoos, DE München, DE	Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB
Employees	Employees 16845% decrease	Employees 1911% increase	Employees 4007% decrease
Valuation ($)	Valuation ($) 1.6 b	Valuation ($) N/A	Valuation ($) 188.5 m
Financial
Revenue (est.)	Revenue (est.) $1.1b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $178m (FY, 2024)
Cost of goods	Cost of goods $73m (FY, 2025)	Cost of goods N/A	Cost of goods $70k (FY, 2024)
Gross profit	Gross profit $1.1b (FY, 2025)	Gross profit N/A	Gross profit $178m (FY, 2024)
Net income	Net income $440.3m (FY, 2025)	Net income N/A	Net income ($70.8m) (FY, 2024)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 95.4m	Total funding raised $ 107.5m